Cited In for PMID: 33718398

Year	Number of Results
2021	13
2022	27
2023	40
2024	7

1

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review.

Delli Bovi AP, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P. Delli Bovi AP, et al. Front Med (Lausanne). 2021 Feb 26;8:595371. doi: 10.3389/fmed.2021.595371. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33718398 Free PMC article. Review.

2

Comprehensive Transcriptome Profiling of Antioxidant Activities by Glutathione in Human HepG2 Cells.

Uchida Y, Ferdousi F, Takahashi S, Isoda H. Uchida Y, et al. Molecules. 2024 Feb 29;29(5):1090. doi: 10.3390/molecules29051090. Molecules. 2024. PMID: 38474603 Free PMC article.

3

Unraveling Adipose Tissue Dysfunction: Molecular Mechanisms, Novel Biomarkers, and Therapeutic Targets for Liver Fat Deposition.

Lopez-Yus M, Hörndler C, Borlan S, Bernal-Monterde V, Arbones-Mainar JM. Lopez-Yus M, et al. Cells. 2024 Feb 22;13(5):380. doi: 10.3390/cells13050380. Cells. 2024. PMID: 38474344 Free PMC article. Review.

4

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond.

Soto A, Spongberg C, Martinino A, Giovinazzo F. Soto A, et al. Biomedicines. 2024 Feb 8;12(2):397. doi: 10.3390/biomedicines12020397. Biomedicines. 2024. PMID: 38397999 Free PMC article. Review.

5

Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction.

LeFort KR, Rungratanawanich W, Song BJ. LeFort KR, et al. Cell Mol Life Sci. 2024 Jan 12;81(1):34. doi: 10.1007/s00018-023-05061-7. Cell Mol Life Sci. 2024. PMID: 38214802 Free PMC article. Review.

6

Association between Estimated Pulse Wave Velocity and Incident Nonalcoholic Fatty Liver Disease in Korean Adults.

Kim BS, Kim HJ, Shin JH. Kim BS, et al. Pulse (Basel). 2023 Dec 2;12(1):1-11. doi: 10.1159/000535580. eCollection 2024 Jan-Dec. Pulse (Basel). 2023. PMID: 38179088

7

The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: evidence from translational studies.

Salvoza N, Giraudi P, Gazzin S, Bonazza D, Palmisano S, de Manzini N, Zanconati F, Raseni A, Sirianni F, Tiribelli C, Rosso N. Salvoza N, et al. J Transl Med. 2023 Dec 11;21(1):906. doi: 10.1186/s12967-023-04770-8. J Transl Med. 2023. PMID: 38082368 Free PMC article.

8

Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects.

Al Jadani JM, Albadr NA, Alshammari GM, Almasri SA, Alfayez FF, Yahya MA. Al Jadani JM, et al. Nutrients. 2023 Nov 11;15(22):4755. doi: 10.3390/nu15224755. Nutrients. 2023. PMID: 38004149 Free PMC article.

9

Ramon Flour (Brosimum alicastrum Swartz) Ameliorates Hepatic Lipid Accumulation, Induction of AMPK Phosphorylation, and Expression of the Hepatic Antioxidant System in a High-Fat-Diet-Induced Obesity Mouse Model.

Cu-Cañetas TE, Velázquez-Villegas LA, Manzanilla-Franco M, Ayora-Talavera TDR, Acevedo-Fernández JJ, Barbosa-Martín E, Márquez-Mota CC, López-Barradas AM, Noriega LG, Guevara-Cruz M, Gutiérrez-Solís AL, Avila-Nava A. Cu-Cañetas TE, et al. Antioxidants (Basel). 2023 Nov 2;12(11):1957. doi: 10.3390/antiox12111957. Antioxidants (Basel). 2023. PMID: 38001809 Free PMC article.

10

The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.

Sawada K, Chung H, Softic S, Moreno-Fernandez ME, Divanovic S. Sawada K, et al. Cell Metab. 2023 Nov 7;35(11):1852-1871. doi: 10.1016/j.cmet.2023.10.009. Cell Metab. 2023. PMID: 37939656 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year